Lorcaserin Extended-Release Tablets and Pneumococcal 13-valent conjugate vaccine
Determining the interaction of Lorcaserin Extended-Release Tablets and Pneumococcal 13-valent conjugate vaccine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal Conjugate Vaccine (13-Valent)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Lorcaserin Extended-Release Tablets-Pneumococcal Conjugate Vaccine (13-Valent)
- Lorcaserin Extended-Release Tablets-Pneumococcal Conjugate Vaccine (7-Valent)
- Lorcaserin Extended-Release Tablets-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Lorcaserin Extended-Release Tablets-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Lorcaserin Extended-Release Tablets-Pneumovax 23
- Pneumococcal 13-valent conjugate vaccine-Lorcaserin Hydrochloride
- Pneumococcal 13-valent conjugate vaccine-Lorcaserin Tablets
- Pneumococcal 13-valent conjugate vaccine-Lorcet
- Pneumococcal 13-valent conjugate vaccine-Lorcet Plus
- Pneumococcal 13-valent conjugate vaccine-Lorcet Tablets
- Pneumococcal 13-valent conjugate vaccine-Lorlatinib